Serum cytokines markers in toluene diisocyanate-induced asthma  by Kim, Joo-Hee et al.
Respiratory Medicine (2011) 105, 1091e1094ava i lab le at www.sc iencedi rec t .com
journa l homepage: www.e lsev ier .com/ locate / rmedSHORT COMMUNICATION
Serum cytokines markers in toluene
diisocyanate-induced asthma*Joo-Hee Kim, Jeong-Eun Kim, Gil-Soon Choi, Hyun-Young Kim,
Young-Min Ye, Hae-Sim Park*Department of Allergy and Rheumatology, Ajou University School of Medicine, San-5, Wonchon-dong, Yeongtong-gu, Suwon
442-749, South Korea
Received 24 November 2010; accepted 3 March 2011
Available online 24 March 2011KEYWORDS
Toluene diisocyanate
(TDI);
Occupational asthma;
Cytokines;
Matrix
metalloproteinase-9
(MMP-9)* This work was supported by a Kore
government.
* Corresponding author. Tel.: þ82 31
E-mail address: hspark@ajou.ac.kr
0954-6111/$ - see front matter ª 201
doi:10.1016/j.rmed.2011.03.005Summary
Background: Toluene diisocyante-induced occupational asthma (TDI-OA) is an inflammatory
disease of airway, composing inflammatory cells and cytokines associated with airway remo-
deling. Majority of the patients with TDI-OA presented persistent asthma. Therefore, early
diagnosis is essential for the favorable prognosis. We investigated to identify serologic markers
for early diagnosis of TDI-OA.
Methods: We enrolled 69 patients with TDI-OA and 95 asymptomatic exposed controls
(AECs). Neutrophil-related cytokines, including myeloperoxidase (MPO) and interleukin-8
(IL-8), as well as airway remodeling-related cytokines, including transforming growth
factor-b1 (TGF-b1), metalloproteinase-9 (MMP-9), tissue inhibitor of metalloproteinase-1
(TIMP-1), and vascular endothelial growth factor (VEGF), were measured by ELISA in the sera
of each subject. To evaluate the validity of the each cytokine and combined cytokines for
discriminating between TDI-OA and AEC, Receiver operating characteristic (ROC) curve
was used.
Results: There were significant differences in the serum levels of MMP-9 and VEGF
between two groups (p < 0.05). Using the optimal cutoff value of MMP-9 (182.96 ng/
mL), the sensitivity and specificity were 79.7% and 80.0%, respectively, with the area
under the curve (AUC) of 0.815. When the cytokines were combined to improve sensitivity,
the combined values of MMP-9, VEGF, and IL-8 comprised the best set, for which the AUC
increased to 0.822 and the sensitivity increased to 82.6% but specificity decreased to
75.8%.an Science and Engineering Foundation (KOSEF) grant (MEST, 2009-00786746) funded by the Korean
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1092 J.-H. Kim et al.Table 1 Clinical features of the
Sex (male/female)
Age (years)
Atopy (%)
Smoker (%)a
FEV1 (%)b
PC20 (mg/mL)
Duration of exposure (years)
Total IgE (IU/mL)
IgG to CK19 (%)
sIgG to TDI-HSA (%)
sIgE to TDI-HSA (%)
All values are presented as mean 
control; NA, not applicable; ND, not
serum albumin; sIgG, serum-specific
a Current and ex-smoker.
b Performed before the methachoConclusions: The single serum cytokine MMP-9 level or the combined cytokines MMP-9,
VEGF, and IL-8 can be used as meaningful serologic markers for identifying patients with
TDI-OA among exposed workers.
ª 2011 Elsevier Ltd. All rights reserved.Introduction
Toluene diisocyanate-induced occupational asthma (TDI-
OA) is the most common occupational asthma, which is
characterized by hyperresponsiveness, inflammation, and
remodeling of the airways.1,2 This inflammation is associ-
ated with the infiltration of various inflammatory cells and
chemical mediators.3 Neutrophils in the lung may
contribute to TDI-induced bronchoconstriction, which may
involve myeloperoxidase (MPO) and interleukin-8 (IL-8).4,5
Increased production of matrix metalloproteinase-9 (MMP-
9), tissue inhibitor of metalloproteinase-1 (TIMP-1),6,7
vascular endothelial growth factor (VEGF), and trans-
forming growth factor-b1 (TGF-b1) have been detected in
the bronchoalveolar lavage (BAL), sputum, or lung tissue of
patients or mouse models of TDI-induced asthma.8,9 Long-
term follow-up studies have revealed that more than 50% of
patients with TDI-OA experience persistent asthmatic
symptoms.9 Many studies have focused on developing tools
for the early diagnosis of TDI-OA in exposed workers. The
use of TDI-specific antibodies or IgG antibodies to cyto-
keratin 19 as biologic markers for TDI-OA has been evalu-
ated; however, the sensitivities were too low to be
applied.10e14 Therefore, we measured the levels of serum
cytokines in patients with TDI-OA and compared them with
those of the AEC group, and sought to identify a new
serologic marker for screening potential asthmatic subjects
among TDI-exposed individuals.
Materials and methods
Sixty-nine patients with TDI-OA, confirmed by positive response
to a TDI bronchoprovocation test,4 and 95 asymptomaticstudy subjects.
TDI-OA (n Z 69)
40/29
42.6  9.9
44.8
34.4
83.1  23.3
6.5  9.6
6.7  0.8
265.8  48.7
25
22.7
25.4
SD. TDI-OA, Toluene diisocyana
done; CK, cytokeratin; sIgE, ser
IgG antibodies.
line challenge test.exposed workers, as asymptomatic exposed controls (AEC),
were enrolled. All the subjects remained in exposed state at
their working environment during the study period. Demo-
graphic data of the study subjects were summarized in Table
1. Serum samples from the subjects were collected before
the treatments; TDI-OA asthmatics stopped using anti-leuko-
trines and anti-inflammatory agents including inhaled or oral
steroids for one week before the study. Serum samples were
stored at 70 C until cytokine and immunological assay. The
cytokine levels were measured using a commercially available
ELISA kit (MPO: BioCheck Inc, Foster City, CA; MMP-9, IL-8,
TGF-b1, and VEGF: R&D Systems Inc., Minneapolis, MN; TIMP-
1: cat. no. RPN 2618; Amersham Pharmacia Biotech, Amer-
sham, U.K.). 2, 4-TDI-human serum albumin (HSA) conjugates
were prepared using a modified version of Tse and Pesce’s
method.11 Serum-specific IgG and IgE levels against the TDI-
HSA conjugate and serum-specific IgG levels against CK 19
were measured by ELISA, as described previously.11,15 The
positive cutoff value was determined as the mean absorbance
of 120 unexposed healthy control subjects plus 2 SD. All
subjects gave their informed consent, which was regulated by
the Institutional Review Board of Ajou Medical Center, Suwon,
Korea.
ManneWhitney U test was used to compare the serum
cytokines between the two groups. Logistic regression
analysis was applied to control for age, sex, smoking status
and exposure duration as covariables. p - value of 0.05
was considered to be significant. Receiver operating char-
acteristic (ROC) curves were used to evaluate the validity
of the serum cytokines for discriminating between TDI-OA
and AEC, and the area under the curve (AUC) with a 95% CI
was computed. Sensitivity and specificity were calculated
according to the identified optimal cutoffs. Bonferroni’s
test was used for multiple comparisons.AEC (n Z 95) p-value
68/27 0.428
41.1  8.2 0.288
ND NA
53.6 0.020
ND NA
ND NA
11.2  1.8 0.016
157.2  38.2 0.037
5.3 < 0.001
9.5 < 0.001
3.2 < 0.001
te - induced occupational asthma; AEC, asymptomatic exposed
um-specific IgE antibodies; TDI-HSA, toluene diisocyanate-human
Table 2 Profile of serum cytokines in TDI-OA and AEC.
TDI-OA (n Z 69) AEC (n Z 95) Unadjusted p-value Adjusted p-value
MMP-9 (ng/mL) 94.00 (127.81) 288.05 (209.85) <0.001 <0.001
MMP-9/TIMP-1 1.41 (2.09) 4.06 (3.74) <0.001 0.072
IL-8 (pg/mL) 15.37 (25.38) 39.42 (47.39) <0.001 0.648
MPO (ng/mL) 93.88 (161.19) 155.33 (169.39) 0.001 0.177
VEGF (pg/mL) 269.00 (339.92) 211.07 (177.65) 0.015 0.017
TGF-b1 (ng/mL) 39.10 (18.47) 42.73 (13.55) 0.181 0.417
TIMP-1 (ng/mL) 68.00 (37.23) 72.84 (18.87) 0.470 0.473
All data are presented as median (interquantile range). Logistic regression analysis was applied to control for age, sex, smoking status
and exposure duration as covariables. TDI-OA, Toluene diisocyanate - induced occupational asthma; AEC, asymptomatic exposed
control; MMP-9, matrix metalloproteinase-9; VEGF, vascular endothelial growth factor; TIMP-1, tissue inhibitor of metalloproteinase-1;
IL-8, interleukin-8; TGF-b1, transforming growth factor-beta1; MPO, myeloperoxidase.
Table 3 Sensitivity, specificity, and values of area under the ROC curve with 95% CI and p-values of various combinations of
cytokines to identify TDI-OA among exposed workers.
Rank Variables Sensitivity (%) Specificity (%) AUC p-value
1 MMP-9 & VEGF & IL-8 82.6 75.8 0.822 <0.001
2 MMP-9/TMIP-1 & VEGF & IL-8 82.6 71.6 0.801 <0.001
3 MMP-9 & VEGF & TGF-b1 81.2 76.8 0.809 <0.001
4 MMP-9 & VEGF & MMP-9/TIMP-1 81.2 75.8 0.803 <0.001
5 MMP-9 79.7 80.0 0.815 <0.001
6 MMP-9/TIMP-1 73.9 69.5 0.734 <0.001
7 IL-8 71.0 71.6 0.745 <0.001
8 VEGF 69.6 49.5 0.596 0.052
TDI-OA, Toluene diisocyanate - induced occupational asthma; AEC, asymptomatic exposed control; MMP-9, matrix metalloproteinase-9;
TIMP-1, tissue inhibitor of metalloproteinase-1; IL-8, interleukin-8; MPO, myeloperoxidase; VEGF, vascular endothelial growth factor;
TGF-b1, transforming growth factor-beta1.
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Table 1 listed the baseline clinical features of the study
subjects. The mean FEV1 and PC20 in TDI-OA were
83.1  23.3% and 6.5  9.6 mg/mL, respectively (Table 1).
The serum level of MMP-9 was significantly lower in TDI-OA
than in AEC, whereas the serum level of VEGF was signifi-
cantly higher in TDI-OA (Table 2). We evaluated the diag-
nostic performance of each cytokine in discriminating
between subjects in TDI-OA and AEC by analyzing the AUC
that was computed from the ROC curve. AUC values were
found to be 0.872 for MMP-9, 0.794 for MMP-9/TIMP-1,
0.744 for IL-8 and 0.016 for VEGF with statistical signifi-
cance (p < 0.001). The AUC for MMP-9 was the highest and
then, we selected the appropriate cutoff values for each
ROC curve. Using the cutoff for MMP-9 (182.96 ng/mL), the
sensitivity and specificity were 79.7% and 80.0%, respec-
tively, with an AUC value of 0.815 (95% CI, 0.74e0.89;
p < 0.001). The other cytokinesdMMP-9/TIMP-1, IL-8, and
VEGFdhaving displayed statistical differences between the
two groups, were analyzed by the same method (Table 3).
When each cytokine was combined to improve sensitivity
and specificity, the combination of MMP-9, VEGF, and IL-8
was the best, with the AUC value increasing to 0.822 (95%
CI, 0.752e0.894; p < 0.001) and the sensitivity increasing
to 82.6% but specificity decreasing to 75.8%, respectively.Discussion
In this study, we found significant differences in the serum
levels of cytokines MMP-9 and VEGF between TDI-OA and
AEC. Among them, MMP-9 is the most prominent cytokine,
displaying high sensitivity and specificity using the specific
cutoff value. Elevation in the levels of MMP-9 in bronchial
mucosal biopsies, BAL, and in induced sputum specimens
have been found in TDI-OA.6,16,17 In recent, a longitudinal
study of patients with diisocyanate-induced asthma showed
that inhaled steroid medication increased BAL levels of
MMP-9, which were correlated inversely with Th-2 type
inflammation.17 In the animal experiment, MMP-9 depleted
mice showed increased inflammatory cells aberrantly
and fewer eosinophils and neutrophils in their lungs
after allergen challenge. These aberrant cellular trafficking
patterns were caused by disruption of transepithelial che-
mokine gradients, indicating that MMP-9 plays a role in the
resolution of airway inflammation.18,19 From this study,
serum level of MMP-9 was significantly lower in the patients
with TDI-OA than AEC, which may be associated with the
protective role of MMP-9. Decreased serum MMP-9 level in
TDI-OA in our study may be due to compartmentalization of
inflammatory cells. However, further studies to clarity the
relationship MMP-9 levels from serum and lung and degree
of airway remodeling will be needed.
1094 J.-H. Kim et al.VEGF contributed to airway obstruction and migration of
inflammatory cells in a mouse model of TDI asthma.20
Serum VEGF was significantly higher in TDI-OA than in AEC
in this study, which are similar results in the patients with
allergic asthma.21
This study is the first to evaluate the serum levels of
various cytokines related to the pathogenesis of TDI-OA
compared to an AEC group. Significant differences were
noted in the serum levels of MMP-9 and VEGF between TDI-
OA and AEC. Considering the costebenefit and applicability
in clinical practice, MMP-9 can be the better serologic
marker for predicting TDI-OA.Conflict of interest
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